Developing an Implementation Blueprint for the NIH HEAL Initiative GRACE Trial: Perspectives on Acupuncture and Guided Relaxation for Chronic Sickle Cell Disease Pain.
Developing an Implementation Blueprint for the NIH HEAL Initiative GRACE Trial: Perspectives on Acupuncture and Guided Relaxation for Chronic Sickle Cell Disease Pain.
复制标题
为 NIH HEAL Initiative GRACE 试验制定实施蓝图：针灸和引导放松治疗慢性镰状细胞病疼痛的观点。
DOI：
10.1089/jicm.2022.0781
复制
发表时间：
2023
期刊：
影响因子：
--
通讯作者：
Patil,CrystalL
中科院分区：
文献类型：
--
作者：
Knisely,MitchellR;Rivera,Eleanor;deMartelly,VictoriaA;Abdulkadir,Aisha;Doorenbos,ArdithZ;Ezenwa,MiriamO;Molokie,RobertE;Li,Hongjin;Shah,Nirmish;Schlaeger,JudithM;Patil,CrystalL
目的：本研究旨在探讨镰状细胞病（SCD）患者和SCD诊所提供者和工作人员对使用针灸和引导放松治疗慢性SCD疼痛的看法。获得的数据是通知实施蓝图的有效性实施临床试验（GRACE试验）测试针灸或引导放松是否减少慢性疼痛时，与平时care.Design相比：定性research design.Methods：我们进行了33个半结构化的采访与SCD和SCD诊所的供应商和工作人员的人。访谈记录被转录和编码。演绎内容分析过程被用来识别themes.Results：四个主题被确定：接受针灸和引导放松，有限的意识，补充和综合健康（CIH）治疗偏好，和访问障碍。患者和诊所提供者和工作人员都对使用针灸和引导放松治疗慢性疼痛持开放态度。在了解这些CIH疗法后，一些患者表示更喜欢一种疗法。他们还讨论了他们成功参与每种治疗的能力。有必要通过增加对每种疗法如何实施和发挥作用以减轻疼痛的理解来消除对疗法的误解。我们确定了几个潜在的障碍，可能会影响成功的试验和未来的卫生系统集成，包括时间，运输，和technology.Conclusion：这项研究是第一个提出的观点，SCD患者和诊所供应商和工作人员对使用针灸和指导放松慢性SCD疼痛。利益相关者的早期投入和观点强调，他们欢迎非药物CIH疗法。实施临床试验和未来的卫生系统整合将需要解决错误信息和确定策略，以克服访问障碍。临床试验注册号：NCT 04906447。
Objective:This study aimed to explore perspectives of people living with sickle cell disease (SCD) and SCD clinic providers and staff about the use of acupuncture and guided relaxation for treating chronic SCD pain. Data obtained were to inform an implementation blueprint for an effectiveness implementation clinical trial (GRACE Trial) testing whether acupuncture or guided relaxation reduces chronic pain when compared with usual care.Design:Qualitative research design.Methods:We conducted 33 semistructured interviews with people with SCD and SCD clinic providers and staff. Interviews were transcribed and coded. A deductive content analysis process was used to identify themes.Results:Four themes were identified: Receptivity to Acupuncture and Guided Relaxation, Limited Awareness, Complementary and Integrative Health (CIH) Therapy Preference, and Access Barriers. Both patients and clinic providers and staff were open to the use of acupuncture and guided relaxation for chronic pain treatment. After learning about these CIH therapies, some patients expressed a preference for one therapy over the other. They also discussed their ability to successfully engage with each therapy. There is a need to dispel misconceptions about the therapies by increasing understanding of how each therapy is implemented and functions to reduce pain. We identified several potential barriers that might affect the success of the trial and future health system integration, including time, transportation, and technology.Conclusion:This study is one of the first to present perspectives of both patients with SCD and clinic providers and staff on the use of acupuncture and guided relaxation for chronic SCD pain. Stakeholders' early input and perspectives highlighted that they welcome nonpharmacological CIH therapies. Implementation of a clinical trial and future health system integration will require the addressing misinformation and identifying strategies to overcome access barriers.Clinical trial registration number:NCT04906447.